Costimulation blockade, busulfan, and bone marrow promote titratable macrochimerism, induce transplantation tolerance, and correct genetic hemoglobinopathies with minimal myelosuppression

MLA

David R. Archer, et al. “Costimulation Blockade, Busulfan, and Bone Marrow Promote Titratable Macrochimerism, Induce Transplantation Tolerance, and Correct Genetic Hemoglobinopathies with Minimal Myelosuppression.” Journal of Immunology (Baltimore, Md. : 1950), vol. 167, no. 2, July 2001. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d837f37c8c4eb8592b5d544fb129c3d0&authtype=sso&custid=ns315887.

APA

David R. Archer, Megan M. Durham, Matthew A. Williams, Thomas C. Pearson, Nozomu Shirasugi, Leslie S. Kean, Phyllis Rees, Christian P. Larsen, Jongwon Ha, Andrew B. Adams, Stephen Mittelstaedt, Michael C. Cheung, Adam W. Bingaman, & Edmund K. Waller. (2001). Costimulation blockade, busulfan, and bone marrow promote titratable macrochimerism, induce transplantation tolerance, and correct genetic hemoglobinopathies with minimal myelosuppression. Journal of Immunology (Baltimore, Md. : 1950), 167(2).

Chicago

David R. Archer, Megan M. Durham, Matthew A. Williams, Thomas C. Pearson, Nozomu Shirasugi, Leslie S. Kean, Phyllis Rees, et al. 2001. “Costimulation Blockade, Busulfan, and Bone Marrow Promote Titratable Macrochimerism, Induce Transplantation Tolerance, and Correct Genetic Hemoglobinopathies with Minimal Myelosuppression.” Journal of Immunology (Baltimore, Md. : 1950) 167 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d837f37c8c4eb8592b5d544fb129c3d0&authtype=sso&custid=ns315887.